Suppress the tic.
Preserve the mind.

A headband that detects when a tic is coming and stops it — without pills, without brain fog, without losing yourself.

Join waitlist
InhibiTic headband
The problem

The pills stop tics.
They also stop you.

Current Tourette medication floods your brain with dopamine blockers. Yes, the tics slow down. But so does everything else. Your thinking. Your creativity. Your emotions. Most people quit — not because the pills don't work, but because the side effects are worse.

70%
Report cognitive side effects
1 in 2
Quit medication within a year
1 in 160
Children have Tourette syndrome
Zero
Treatments preserve both cognition and agency
Our approach

A split-second nudge.
Only when needed.

InhibiTic doesn't pump drugs through your brain. It doesn't stimulate continuously. It listens for the feeling that comes right before a tic — and at that exact moment, it delivers a tiny electrical pulse to the part of your brain that says "stop." Then it goes quiet. Your brain stays yours.

How it works
01 — Sense
The headband reads your brain signals 256 times per second. It learns your unique "tic is coming" pattern.
02 — Act
Within 50 milliseconds, a tiny painless pulse gives your brain's "stop" circuit a split-second boost.
03 — Rest
The moment the urge passes, the pulse stops. No lingering effects. No fog. No withdrawal.
Learn more

Pills vs. InhibiTic

One approach floods your brain. The other targets only what matters.

Medication
InhibiTic
What it affects
Your whole brain
Only the part that stops tics
Side effects
Brain fog. Numb. Slow thinking.
None. Active seconds at a time.
Who is in control
The drug
You. It helps when you ask.
Form factor
A pill bottle
A headband. Wear it under a hat.
Your data
Nothing
Tracks tics and brain health.
The device

It is a headband.
That is the point.

Under 80 grams. Fabric sensors woven in. No gel. No wires. It looks like a slim athletic headband. Nobody can tell.

8 hr
Battery life — full workday
<80 g
Total weight
8
Dry EEG sensors — no gel
50 ms
Detection to stimulation

Stay informed

Updates on development, early access, and clinical trials.

You are on the list.

Your email is used only for product updates.